Mangalam Drugs (MANGALAM) | Stock Overview & Key Data

Mangalam Drugs and Organics Ltd. | Small-cap | Healthcare

₹80.31

1.44%

| Mangalam Drugs Stock Comparison:

No comparison data available

Chart Range Statistics Financials Returns Ownership Calculator FAQ

Mangalam Drugs Performance Comparison

Loading chart data...

Mangalam Drugs

NIFTY 50

View Full Price History

Stock Range

Today's Range

Low: ₹79.96 High: ₹81.49

on June 27, 2025

52 Week Range

Low: ₹70.10 High: ₹144.99

on May 9, 2025

on August 26, 2024

All-Time High: ₹442.40 on December 7, 2015

Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights

Key Statistics

Market Cap i INR1.3B

EPS i 4.25

P/E Ratio (TTM) i 18.94

Forward P/E i N/A

P/B Ratio i 0.80

PEG Ratio i -0.11

Div. Yield i N/A

ROE i 4.72%

Beta i -0.064

Debt to Equity i 64.59

Financial Highlights

Profitability

Gross Margin i 51.41%

Operating Margin i 7.49%

Profit Margin i 2.12%

Returns and Earnings

Return on Assets (TTM) i 3.43%

Return on Equity (TTM) i 4.72%

EBITDA i INR363.3M

Net Income (TTM) i INR67.2M

Growth

Revenue (TTM) i

Revenue Per Share (TTM) i

Quarterly Revenue Growth i

Quarterly Earnings Growth i

Peer Performance Comparison

No peer performance data available for this stock.

Ownership & Short Interest

Insider Ownership i 54.59%

Institutional Ownership i 0.00%

Shares Short i N/A

Short Ratio i N/A

Short % of Shares Outstanding i N/A

Average 10-Day Volume i 27K

Average 90-Day Volume i 30K

Mangalam Drugs Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Mangalam Drugs would have performed over time.

Investment Amount

INR

Investment Frequency

Start Date

End Date (Optional)

If not specified, the latest available data will be used

Reinvest Dividends

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

What is MANGALAM's 52-week high and low?

In the last 52 weeks, Mangalam Drugs reached a high of ₹144.99 (on August 26, 2024) and a low of ₹70.10 (on May 9, 2025).

What is the market cap and P/E ratio for MANGALAM?

Curious about Mangalam Drugs's size and valuation? Its market capitalization stands at 1.27B. When it comes to valuation, the P/E ratio (trailing twelve months) is 18.94, and the forward P/E (looking ahead) is N/A.

Does MANGALAM pay dividends? If so, what's the yield?

As for dividends, Mangalam Drugs isn't currently offering a significant yield, or that specific data isn't available right now.

Who are Mangalam Drugs's main competitors or similar companies to consider before investing?

When looking at Mangalam Drugs, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

No specific competitor data is currently available for comparison in this section.

What are the key financial health indicators for Mangalam Drugs and Organics Ltd.? (e.g., ROE, Debt/Equity)

To get a sense of Mangalam Drugs's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 4.72%, the Debt to Equity ratio from the most recent quarter is 64.59, and its Gross Profit Margin stands at 51.41%.

What is the recent revenue and earnings growth for MANGALAM?

Looking at Mangalam Drugs's growth, its revenue over the trailing twelve months (TTM) was INR3B. Compared to the same quarter last year (YoY), quarterly revenue grew by -28.60%, and quarterly earnings saw a YoY growth of -98.30%.

How much of MANGALAM stock is held by insiders and institutions?

Wondering who owns Mangalam Drugs stock? Company insiders (like executives and directors) hold about 54.59% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.